Andere Sprachen Azure Health Technology Australian S.E.

Aktien

A2PEC4

AZT

Schlusskurs Australian S.E. Andere Börsenplätze			% 5 Tage	% 1. Jan.
- ^AUD	-.--%		-.--%	-.--%

08.02.	VGI Health Technology Limited berichtet über die Ergebnisse für das am 31. Dezember 2023 endende Halbjahr	CI
2023	VGI Health Technology Limited meldet Ergebnis für das am 30. Juni 2023 endende Geschäftsjahr	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

VGI Health Technology Limited New Partnership	14.02.
VGI Health Technology Limited (NSX:VTL) New Partnership	14.02.
VGI Health Technology Limited Reports Earnings Results for the Half Year Ended December 31, 2023	08.02.
VGI Health Technology Limited HREC Approval for Phase II Clinical Study	10.01.
VGI Health Technology Limited Reports Earnings Results for the Full Year Ended June 30, 2023	07.09.23
VGI Health Technology Limited commences divestment of Invictus BioPharma Pty Ltd	29.08.23
VGI Health Technology Limited (NSX:VTL) commences divestment of Invictus BioPharma Pty Ltd	29.08.23
Certain Ordinary Shares of VGI Health Technology Limited are subject to a Lock-Up Agreement Ending on 28-MAY-2023.	28.05.23
VGI Health Technology Limited Reports Earnings Results for the Half Year Ended December 31, 2022	16.02.23
VGI Health Technology Limited Quarterly Update	30.01.23
VGI Health Technology Limited (NSX:VTL) Quarterly Update	30.01.23
VGI Health Technology Limited Update on Sale of Invictus BioPharma	21.12.22
VGI Health Technology Limited (NSX:VTL) Update on Sale of Invictus BioPharma	21.12.22
VGI Health Technology Limited R & D Facility Agreement with Fundsquire Pty Ltd	13.10.22
VGI Health Technology Limited (NSX:VTL) R & D Facility Agreement with Fundsquire Pty Ltd	13.10.22
VGI Health Technology Limited NAFLD/NASH Phase II Clinical Study	04.10.22
VGI Health Technology Limited (NSX:VTL) NAFLD/NASH Phase II Clinical Study	04.10.22
VGI Health Technology Limited Receives Ethics Approval for US Clinical Study	25.09.22
VGI Health Technology Limited NAFLD/NASH PhaseII Clinical Study Recruits 1st Patient	13.09.22
VGI Health Technology Limited (NSX:VTL) NAFLD/NASH PhaseII Clinical Study Recruits 1st Patient	13.09.22

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Azure Health Technology Australian S.E.

Aktien

A2PEC4

AZT

Andere Sprachen

Filter